Supply Strategy: A Quasi-Experiment on the Number And Location of Suppliers by André Luis de Castro Moura Duarte (6150152)

The impact of a breast cancer diagnosis on health-related quality of life. A prospective comparison among middle-aged to elderly women with and without breast cancer by Randi V. Karlsen (2545756)

“…</p> <p><b>Material and methods</b> The Danish Diet, Cancer and Health study included 57 053 cancer-free persons aged 50–64 years at baseline (1993–1997). We used data from first follow-up (1999–2002) and second follow-up (2010–2012) on HQoL [Medical Outcomes Survey, short form (SF-36)] obtained from 542 women aged 64–82 years with primary breast cancer (stages I–III) and a randomly matched sample of 729 women who remained breast cancer-free. …”

Successful Management of Postoperative Chylothorax in a Neonate after Coarctation Repair by Sameh M. Said (8697503)

Virulence in the infected nematode relies on the catalytic activity of TrxA. by XiaoHui Sem (132320)

“…<p>(A) Survival of wild-type nematodes was compared when fed <i>E. coli</i> OP50, <i>S</i>. …”

Cell population dynamics for the hybrid stochastic-deterministic TMZ-MGMT model. by Anshul Saini (11320669)

S1 File - by Dong-Ju Park (17300283)

“…It is known that hippocalcin exerts anti-apoptotic effect through the modulation of apoptotic pathway. Thus, we can suggest evidence that EGCG has a neuroprotective effect by regulating hippocalcin expression in ischemic brain damage and glutamate-exposed cells.…”

S1 Data - by Dong-Ju Park (17300283)

“…It is known that hippocalcin exerts anti-apoptotic effect through the modulation of apoptotic pathway. Thus, we can suggest evidence that EGCG has a neuroprotective effect by regulating hippocalcin expression in ischemic brain damage and glutamate-exposed cells.…”

Extended territorial (scope 1 and 2) per capita CO₂ emissions and per capita CF by human settlement types in England: 1—major urban (<em>N</em> = 76); 2—large urban (<em... by Jan Minx (557244)

“…Still, little is known about emission patterns across density gradients from remote rural places to highly urbanized areas, the drivers behind those emission patterns and the global emissions triggered by consumption in human settlements—referred to here as the carbon footprint. In this letter we use a hybrid method for estimating the carbon footprints of cities and other human settlements in the UK explicitly linking global supply chains to local consumption activities and associated lifestyles. …”

Spiral Ganglion Cell (SGC) loss as a function of age. by James R. Engle (279198)

“…The packing density of SGCs decreases as a function age and region in the cochlea. …”

DataSheet_2_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.pdf by Ni An (511459)

“…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”

DataSheet_5_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.pdf by Ni An (511459)

“…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”

DataSheet_4_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.pdf by Ni An (511459)

“…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”

DataSheet_3_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.pdf by Ni An (511459)

“…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”

DataSheet_1_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.pdf by Ni An (511459)

“…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”

A linear-nonlinear decoder can detect the flash onset. by Genadiy Vasserman (206694)

“…In the naïve readout, the error does not improve significantly when we add more cells. <b>H</b>. Estimated onset times histogram for a network with 85 cells. …”

Fig 2 - by Yehree Kim (12635646)

A mutant in an acidic patch of Set1 abolishes its interaction with Spp1 but does not affect meiotic DSB formation. by Céline Adam (320770)

Sequence preprocessing information. by Ilze Elbere (3584057)

“…Patients were defined as Responders if their HbA1c levels during three months of metformin therapy had decreased by ≥12.6 mmol/mol (1%), while in Non-responders HbA1c were decreased by <12.6 mmol/mol (1%).…”

Characteristics of the analyzed cohorts. by Ilze Elbere (3584057)

“…Patients were defined as Responders if their HbA1c levels during three months of metformin therapy had decreased by ≥12.6 mmol/mol (1%), while in Non-responders HbA1c were decreased by <12.6 mmol/mol (1%).…”

Multiplex network of the VSTMBT and <i>nQ</i> example. by Avalon Campbell-Cousins (22110646)